Cleveland-Cliffs Inc. (BMV:CLF)
188.70
-11.63 (-5.81%)
At close: Aug 1, 2025, 2:00 PM CST
Inozyme Pharma Revenue
Cleveland-Cliffs had revenue of $4.93B USD in the quarter ending June 30, 2025, a decrease of -3.10%. This brings the company's revenue in the last twelve months to $18.46B, down -12.14% year-over-year. In the year 2024, Cleveland-Cliffs had annual revenue of $19.19B, down -12.78%.
Revenue (ttm)
$18.46B
Revenue Growth
-12.14%
P/S Ratio
0.27
Revenue / Employee
$615.23K
Employees
30,000
Market Cap
94.17B
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.19B | -2.81B | -12.78% |
Dec 31, 2023 | 22.00B | -993.00M | -4.32% |
Dec 31, 2022 | 22.99B | 2.55B | 12.45% |
Dec 31, 2021 | 20.44B | 15.09B | 281.85% |
Dec 31, 2020 | 5.35B | 3.36B | 169.05% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition